(CRSP) Crispr Therapeutics - Performance -3.2% in 12m
CRSP performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-56.20%
#85 in Peer-Group
Rel. Strength
34.48%
#5052 in Stock-Universe
Total Return 12m
-3.21%
#65 in Peer-Group
Total Return 5y
-37.97%
#51 in Peer-Group
P/E | Value |
---|---|
P/E Trailing | - |
P/E Forward | 23.4 |
High / Low | USD |
---|---|
52 Week High | 62.75 USD |
52 Week Low | 31.27 USD |
Sentiment | Value |
---|---|
VRO Trend Strength +-100 | 97.43 |
Buy/Sell Signal +-5 | 2.12 |
Support / Resistance | Levels |
---|---|
Support | |
Resistance |
12m Total Return: CRSP (-3.2%) vs XBI (-6.2%)

5y Drawdown (Underwater) Chart

Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
---|---|---|---|---|---|---|---|---|
GILD NASDAQ Gilead Sciences |
2.94% | 73.2% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
UTHR NASDAQ United Therapeutics |
-9.16% | -5.32% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
AMGN NASDAQ Amgen |
2.99% | -0.49% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
BIM PA Biomerieux |
1.6% | 32.8% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
3.29% | -6.6% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
KMDA NASDAQ Kamada |
17.1% | 57.4% | -4.19% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
PTCT NASDAQ PTC Therapeutics |
-3.2% | 58.3% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
ERF PA Eurofins Scientific SE |
3.23% | 38.8% | 14.5% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: CRSP vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CRSP
Total Return (including Dividends) | CRSP | XBI | S&P 500 |
---|---|---|---|
1 Month | 37.15% | 3.53% | 5.22% |
3 Months | 59.74% | 9.10% | 16.86% |
12 Months | -3.21% | -6.17% | 14.81% |
5 Years | -37.97% | -24.21% | 111.83% |
Trend Score (consistency of price movement) | CRSP | XBI | S&P 500 |
---|---|---|---|
1 Month | 93.2% | 4.4% | 81% |
3 Months | 68.8% | 78.8% | 96.9% |
12 Months | -70.9% | -85.8% | 44.9% |
5 Years | -81.6% | -52.6% | 84% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
---|---|---|---|
1 Month | %th93.00 | 32.47% | 30.34% |
3 Month | %th89.50 | 46.42% | 36.69% |
12 Month | %th67.50 | 3.15% | -15.70% |
5 Years | %th76.00 | -18.16% | -70.72% |
FAQs
Does Crispr Therapeutics (CRSP) outperform the market?
Yes,
over the last 12 months CRSP made -3.21%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.17%.
Over the last 3 months CRSP made 59.74%, while XBI made 9.10%.
Performance Comparison CRSP vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CRSP vs. Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 9.5% | 31.9% | 20.9% | -18% |
US NASDAQ 100 | QQQ | 9.9% | 31.6% | 19.6% | -17% |
German DAX 40 | DAX | 10.5% | 37.8% | 7.4% | -33% |
Shanghai Shenzhen CSI 300 | CSI 300 | 11.2% | 32.9% | 18.1% | -22% |
Hongkong Hang Seng | HSI | 10.5% | 30.8% | 2.5% | -39% |
India NIFTY 50 | INDA | 11.6% | 33.8% | 22.7% | -3% |
Brasil Bovespa | EWZ | 7.5% | 28.9% | -5.8% | -15% |
CRSP vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 10.2% | 30.6% | 16.2% | -30% |
Consumer Discretionary | XLY | 8.8% | 34.3% | 28.8% | -22% |
Consumer Staples | XLP | 9.2% | 37.2% | 21% | -13% |
Energy | XLE | 10.2% | 32.2% | 26.1% | -1% |
Financial | XLF | 9% | 32.7% | 16.9% | -33% |
Health Care | XLV | 10.8% | 34.8% | 28.8% | 1% |
Industrial | XLI | 8.9% | 32.9% | 13.9% | -28% |
Materials | XLB | 7.6% | 32.5% | 16.3% | -9% |
Real Estate | XLRE | 9.7% | 35.9% | 23.2% | -16% |
Technology | XLK | 9.4% | 28.3% | 17.8% | -15% |
Utilities | XLU | 10.9% | 37.1% | 19.5% | -26% |
Aerospace & Defense | XAR | 10.8% | 29.5% | 3.7% | -52% |
Biotech | XBI | 9.9% | 33.6% | 34.9% | 3% |
Homebuilder | XHB | 6.6% | 28.6% | 28.8% | -8% |
Retail | XRT | 6.5% | 32.9% | 25.5% | -14% |
CRSP vs. Commodities
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Oil | USO | 9.5% | 29.6% | 30.7% | 4% |
Natural Gas | UNG | 14.3% | 47.2% | 29.4% | 4% |
Gold | GLD | 11.6% | 37.7% | 1% | -44% |
Silver | SLV | 11.2% | 30.6% | 3% | -24% |
Copper | CPER | 11.1% | 32.2% | 2.3% | -17% |
CRSP vs. Bonds
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
iShares 20+ Years Bond | TLT | 12.5% | 34.5% | 25.4% | -2% |
iShares High Yield Corp. Bond | HYG | 11.3% | 35.4% | 22.4% | -14% |